Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2844 of 5804
-
Zapping away COVID lungs: radiofrequency eases breathlessness
Symptom relief CompletedThe sequelae that occur in post-COVID-19 patients are multiple and, at a therapeutic level, these represent a new challenge within the general context of the pandemic that the world is suffering. The virus has managed to end thousands of lives today and many other cases are bein…
Phase: NA • Sponsor: Clinica Gema Leon • Aim: Symptom relief
Last updated Jun 26, 2026 19:09 UTC
-
AI learns to catch early gut cancers in endoscopy videos
Knowledge-focused Recruiting nowThis study aims to validate and evaluate AI algorithms for detection and characterization of early GI neoplasia.
Sponsor: Portsmouth Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Could amniotic fluid beat steroids for spinal stenosis pain?
Symptom relief CompletedThere is a large population of patients with lumbosacral radicular pain due to spinal stenosis who do not respond to physical therapy or oral medication management, yet wish to avoid spinal surgery or are simply not candidates due to medical co-morbidity. Given the natural histor…
Phase: PHASE1, PHASE2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Gentler C-Section technique could reduce injuries in repeat births
Symptom relief CompletedTo establish feasibility and safety of the use of external pop out as a novel technique for foetal head delivery during c s, the effect of application of this method on a previously scarred uterus will be studied as a better way regarding preservation of the integrity of the lowe…
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New hope for swallowing troubles: brain zaps and muscle therapy show promise
Symptom relief CompletedThis study aims to evaluate different non-invasive and neuromuscular stimulation treatments for neurogenic dysphagia in post-stroke and Parkinson's disease patients. The study is divided into three sub-studies: 1. Unilateral, bihemispheric, or sham transcranial Direct Current St…
Phase: NA • Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation • Aim: Symptom relief
Last updated Jun 26, 2026 12:49 UTC
-
New targeted therapy shows promise for concussion sufferers
Symptom relief CompletedObjective: This 3-year multisite RCT will determine the effectiveness of a targeted multidomain intervention (T-MD) (anxiety/mood, cognitive, migraine, ocular, vestibular; and sleep, autonomic) compared to usual care (behavioral management) in military-aged civilians with complex…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New kidney cancer drug shows promise in early trial
Disease control CompletedThe goal of this study is to evaluate the safety, tolerability and pharmacokinetics of escalating doses of belzutifan as second line positive (2L+) treatment in participants with advanced clear cell renal cell carcinoma (ccRCC).
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a simple mist replace needles for kids' post-surgery pain?
Symptom relief Recruiting nowIn this study we introduce a potent local anesthetic; bupivacaine 0.5% in 0.5 mg/kg dose by nebulization as a preemptive analgesia to compare efficacy and safety in children with cleft palate repair.
Phase: PHASE3 • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New study aims to help cancer survivors manage other health problems
Disease control OngoingThe proposed ONE TEAM Study is an 18-month, cluster randomized controlled trial. This study will use a sequential multiple assignment randomized trial (SMART) design with a second randomization for the intervention group using a dynamic treatment regimen approach. The investigato…
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Bright idea: light therapy may boost sleep and brain function in early Alzheimer's
Symptom relief CompletedTo investigate the impact of a long-term light treatment intervention on sleep physiology and memory in mild cognitively impaired and mild Alzheimer's disease patients living at home. The goal is also to measure the impact of the lighting intervention on caregivers' sleep, cognit…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Could a common supplement help tame type 2 diabetes?
Disease control Recruiting nowType 2 diabetes mellitus (DM2) is characterized by chronic hyperglycemia, which is a risk factor for comorbidities and death. Although conventional pharmacotherapy is effective, some individuals do not reach the glycemic targets, requiring adjuvant therapies. Taurine is a semi-es…
Phase: PHASE2 • Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Disease control
Last updated Jun 26, 2026 18:47 UTC
-
New bone-stabilizing device under real-world watch
Disease control Recruiting nowThis is a multi-center, observational patient registry. The primary objective of the study is to collect safety and performance data on the IlluminOss Device when used to provide stabilization and alignment for the treatment of traumatic or impending and pathologic fractures.
Sponsor: IlluminOss Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New gel aims to soothe common vaginal infection
Disease control Recruiting nowThis is a randomized, double-blind, placebo-controlled clinical investigation. The objective of the study is to confirm the efficacy of Multi-Gyn ActiGel Plus to treat BV as compared to a placebo control. Treatment arm 1: Multi-Gyn ActiGel Plus Treatment arm 2: placebo gel Both …
Phase: NA • Sponsor: BioClin BV • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a magnet on the head ease voice spasms?
Symptom relief Recruiting nowLaryngeal dystonia (LD) causes excessive vocal fold abduction (opening) or adduction (closing) leading to decreased voice quality, job prospects, self-worth and quality of life. Individuals with LD often experience episodic breathy voice, decreased ability to sustain vocal fold v…
Phase: NA • Sponsor: MGH Institute of Health Professions • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Stroke rehab breakthrough: biofeedback and exercise aim to fix walking
Symptom relief OngoingThe goal of this project is to determine the feasibility and optimal parameters of a novel, comprehensive approach to gait training in individuals with chronic stroke. The comprehensive approach includes biofeedback-based gait training and aerobic exercise intensity-based gait tr…
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Could a common gout pill help Veterans' failing hearts?
Disease control CompletedHeart failure with reduced ejection fraction (HFrEF) is a common cause for admission within the Veterans Affairs (VA) Health Care System. It is associated with severe impairment of physical and mental health status and carries a high risk of mortality. Even though significant pr…
Phase: PHASE2, PHASE3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Fish oil for teen depression? new study tests Omega-3 power
Symptom relief Recruiting nowThis is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Blood test could predict leukemia survival
Knowledge-focused CompletedThe investigators have recently demonstrated the strong impact in terms of survivals of Fms-like tyrosine kinase 3 ligand (FL) levels evaluated during intensive induction in acute myeloid leukemia (AML) patients. Indeed, three FL kinetic profiles were delineated: i) sustained inc…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Immunotherapy duo tackles rare nerve cancer in early trial
Disease control CompletedThe purpose of the study is to evaluate safety and feasibility of neoadjuvant nivolumab plus ipilimumab prior to standard therapy (surgery, chemotherapy or radiation therapy) in patients with Neurofibromatosis Type 1 (NF1) and newly diagnosed pre-malignant and malignant periphera…
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Money stress and suicide: new study tests peer coaching to save lives
Knowledge-focused TerminatedFinancial hardship is an important risk factor for suicide. However, there are no evidence-based interventions to help individuals at risk for suicide to improve their financial situation. The intervention will support participants to address their financial difficulties (e.g., i…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC